We specialize in high-precision genomic sequencing techniques, including Human and Viral genome sequencing. Our state-of-the-art equipment and experienced team ensure accurate and comprehensive results.
Our team of skilled geneticists and biotechnologists possesses extensive experience in Human and Viral genomics and related research, ensuring the highest quality of sequencing outcomes.
Pier 23 Labs maintains a cutting-edge laboratory infrastructure, equipped with the latest genomic sequencing technologies and software, enabling us to deliver top-tier sequencing results.
We adhere to strict quality control and compliance measures, meeting and exceeding industry standards to deliver reliable and trustworthy genomic data.
PIER 23 LABS is a leading biotechnology company renowned for its expertise in genomic sequencing and its commitment to advancing scientific research. With a track record of delivering high-quality results and contributing to groundbreaking discoveries, we are proud to be considered a trusted partner for genomic sequencing services.
Pharmaceutical Companies
Healthcare Institutions
Research Organizations
Government Agencies
We would be extremely honored for the opportunity to be considered by US government agencies for sole source, firm fixed-price purchase contract opportunities for human and viral genome sequencing. Our extensive capabilities and expertise in this field make us a strong candidate to fulfill the requirements in many government contracts as they pertain to laboratory testing.
We have a strong reputation for confidentiality, data security, and ethical research practices, making us a trusted partner for sensitive projects.
Pier 23 Labs has a history of successful collaborations with leading research institutions and government agencies, delivering valuable genomic insights.
We understand the urgency of research needs. Our streamlined processes ensure rapid turnaround times without compromising on quality.
Pier 23 Labs has a history of successful collaborations with leading research institutions and government agencies, delivering valuable genomic insights.
We understand the urgency of research needs. Our streamlined processes ensure rapid turnaround times without compromising on quality.
Our team consists of industry veterans with extensive experience in pharmaceutical research. We have experts in various therapeutic areas, ensuring that we can cater to a wide range of research requirements.
Our research processes incorporate the latest technologies, including advanced data analytics tools, AI-driven predictive models, and state-of-the-art lab equipment.
With a history of successful projects and satisfied clients, our research has contributed to the development of groundbreaking therapies.
We strictly adhere to all regulatory standards, ensuring that our research is conducted ethically and produces reliable results.
We understand that every client has unique needs, and we offer tailored research solutions to meet your specific requirements.
Our services extend beyond geographical limitations. With the capability to conduct research globally, we can support clients wherever they are located.
Pier 23 Labs, Inc. is a leading clinical research organization that provides comprehensive and cost-effective drug development services to biotechnology, pharmaceutical, and medical device companies. We specialize in executing clinical trials across a broad range of indications, leveraging our deep expertise, robust infrastructure, and extensive resources.
Our specialty lies in conducting clinical trials for various indications including oncology, CNS, cardiovascular diseases, metabolic disorders, immunology, genetics, respiratory, infectious diseases, musculoskeletal disorders, and hematological disorders. Our team of experts is highly experienced in managing complex clinical trials.
We utilize advanced methodologies in molecular genetics such as PCR and next-generation sequencing to ensure the accuracy and efficiency of our clinical trials. Our streamlined processes, along with our dedicated team of experts, ensure the successful execution of every project.
At Pier 23 Labs, we take pride in our authenticity and transparency. We strive to simplify complex healthcare information, making it easily understandable for our clients. Our focus is not just on providing efficient services, but also on building trust and empowering our clients to take control of their healthcare decisions.
We provide comprehensive services throughout the drug development process, from initial testing to final approval. Our efficient and cost-effective services help pharmaceutical, biotechnology, and medical device companies bring new treatments to market more quickly and affordably.
Yes, we actively seek out government contracts and partnerships. We believe in fostering collaborative relationships to drive innovation and advancements in healthcare.
We welcome partnerships with organizations that share our commitment to improving patient outcomes. For partnership inquiries, please contact us directly and our team will be more than happy to discuss potential collaboration opportunities.
At Pier 23 Labs, we adhere strictly to all ethical guidelines and regulations related to clinical trials. Patient safety is our top priority, and we have robust monitoring and auditing processes in place to ensure this.
We take data privacy very seriously. We have stringent policies in place to ensure the confidentiality and security of all patient data. We comply with all relevant data protection regulations and maintain the highest standards of data privacy
You can learn more about us and our services by visiting our website or contacting us directly. We are always ready to provide information and answer any questions you may have.
100 CARR-165, SUITE 304 GUAYNABO, PR 00968
(CENTRO INTERNACIONAL DE MERCADEO TOWER 1)
Affiliated Companies:
For press inquires contact our media team by email: media@p23labs.com